Biogen Idec and Roche plan to invest in Medicon Valley  

2004.09.21
Key international health industry players including Biogen Idec and Roche are currently searching for new investment projects in Medicon Valley

Key international health industry players including Biogen Idec and Roche are currently searching for new investment projects in Medicon Valley. US giant Biogen Idec is negotiating with Danish biotech companies says Paul J. Coleman, director of Biogen Idec, adding that Biogen Idec has a particularly active interest in the area. Biogen Idec has DKK 9.2 bn (USD 1.5 bn) to invest in budding research based biotech companies.

 

The Swiss pharmaceutical company Roche is negotiating with several Danish companies on collaboration. Peter Hug, international head of Roche's Pharma Partnering division, says the company is very aware of Scandinavian biotech companies and Medicon Valley where exceptionally good research is carried out. In Denmark, Roche already has a partnership agreement with biotech company Genmab. The news is reported by national newspaper Berlingske Tidende.

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×